CVS Camphor Phenol Gel

Manufacturer
CVS | OraLabs, Inc.
Effective date
2015-05-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:47:16

Label at a glance#

ProductCVS Camphor Phenol Gel
Active ingredientCAMPHOR (SYNTHETIC), PHENOL
Label structure8 sections

Indications and uses

For the temporary relief of pain and itching associated with cold sores and fever blisters. First aid to help prevent infection.

Dosage and administration

Adults and children 2 years or over: clean the affected area. Apply directly to the cold sore or fever blister 1 to 3 times daily. Do not bandage. Children under 2 years: ask a doctor.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Camphor (10.8%), Phenol (4.7%)

Purpose

OTC - PURPOSE SECTION

Pain reliever/antiseptic

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. Do not induce vomiting before contacting medical help or a Poison Control Center.

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of pain and itching associated with cold sores and fever blisters. First aid to help prevent infection.

Warnings

WARNINGS SECTION

For external use only. Do not use over large areas of the body or with a bandage. Ask a doctor before use if you have a deep or puncture wound. Animal bites. Serious burns. When using this product do not use near the eye. If contact occurs, rinse eyes thoroughly with water and obtain medical attention.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 2 years or over: clean the affected area. Apply directly to the cold sore or fever blister 1 to 3 times daily. Do not bandage. Children under 2 years: ask a doctor.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Eucalyptus, Glycerin, Mineral Oil, Silica.

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Back Panel of CVS Camphor Phenol Gel Box
Back Panel of CVS Camphor Phenol Gel Box

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308939camphor 10.8 % / phenol 4.7 % Topical GelPSN1
308939camphor 0.108 MG/MG / phenol 0.047 MG/MG Topical GelSCD1
308939camphor 0.11 MG/MG / phenol 0.05 MG/MG Topical GelSY1
308939camphor 10.8 % / phenol 4.7 % Topical GelSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69842-553-012020-01-31C16284748780-19d75b9d0-8e72-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69842-553-01CVS Camphor Phenol Gel1 g in 1 CONTAINERGEL11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69842-553CVS CAMPHOR PHENOL GEL (CAMPHOR, PHENOL) GEL [CVS]1Legacy NDC, 1 package rows20160928_771c6e76-2a28-4b00-bfaf-ec1f6696c5b9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-55369842-553-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
771c6e76-2a28-4b00-bfaf-ec1f6696c5b9771c6e76-2a28-4b00-bfaf-ec1f6696c5b92015-05-04WarningsExact identifier
spl id: 771c6e76-2a28-4b00-bfaf-ec1f6696c5b9
spl set id: 771c6e76-2a28-4b00-bfaf-ec1f6696c5b9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.